Zurcher Kantonalbank Zurich Cantonalbank Has $1.75 Million Stock Holdings in Chemed Co. (NYSE:CHE)

Zurcher Kantonalbank Zurich Cantonalbank grew its position in Chemed Co. (NYSE:CHE) by 23.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,993 shares of the company’s stock after buying an additional 568 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Chemed were worth $1,750,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in CHE. Larson Financial Group LLC bought a new position in Chemed in the third quarter valued at about $44,000. Legacy Financial Group LLC acquired a new position in shares of Chemed in the 3rd quarter valued at $48,000. Covestor Ltd boosted its position in shares of Chemed by 27.4% in the 3rd quarter. Covestor Ltd now owns 144 shares of the company’s stock worth $75,000 after purchasing an additional 31 shares during the last quarter. ORG Partners LLC acquired a new stake in shares of Chemed during the third quarter worth $126,000. Finally, Silver Oak Securities Incorporated bought a new stake in Chemed in the third quarter valued at about $126,000. Institutional investors own 95.85% of the company’s stock.

Insider Transactions at Chemed

In other Chemed news, EVP Spencer S. Lee sold 2,000 shares of Chemed stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the sale, the executive vice president now owns 20,760 shares of the company’s stock, valued at approximately $13,320,654. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, VP Brian C. Judkins sold 11,158 shares of Chemed stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the completion of the sale, the vice president now owns 1,422 shares of the company’s stock, valued at $917,190. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Spencer S. Lee sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the sale, the executive vice president now directly owns 20,760 shares in the company, valued at approximately $13,320,654. The disclosure for this sale can be found here. Insiders sold 15,808 shares of company stock valued at $10,184,531 over the last quarter. Corporate insiders own 3.32% of the company’s stock.

Chemed Trading Up 0.2 %

Shares of Chemed stock opened at $617.56 on Thursday. The stock’s fifty day simple moving average is $623.23 and its 200 day simple moving average is $590.47. The company has a market capitalization of $9.34 billion, a PE ratio of 34.46, a PEG ratio of 2.43 and a beta of 0.42. Chemed Co. has a 12 month low of $492.84 and a 12 month high of $654.62.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, February 27th. The company reported $6.60 EPS for the quarter, topping analysts’ consensus estimates of $6.25 by $0.35. Chemed had a return on equity of 32.29% and a net margin of 12.03%. The company had revenue of $585.90 million for the quarter, compared to analyst estimates of $586.64 million. During the same quarter last year, the firm posted $5.39 earnings per share. Chemed’s revenue was up 7.2% compared to the same quarter last year. Analysts predict that Chemed Co. will post 21.99 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.26%. The ex-dividend date was Friday, February 23rd. Chemed’s dividend payout ratio (DPR) is presently 8.93%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CHE. Royal Bank of Canada raised their target price on Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a report on Monday, March 4th. Oppenheimer lifted their price objective on shares of Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Thursday, February 29th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.